A pharmaceutical composition for treatment of wounds is disclosed in the present invention. The pharmaceutical composition is Bispecific Agonist (BA) proteins comprising an Interleukin-7 (IL-7) and an epidermal growth factor (EGF) for treatment of acute or chronic wounds as well as immune suppressive conditions in p...
Documents
Form INC-20A-02082022_signed
Form ADT-1-02082022_signed
Copy of written consent given by auditor-01082022
Copy of the intimation sent by company-01082022
Copy of resolution passed by the company-01082022
-01082022
Form INC-22-11072022_signed
Proof of Registered Office address(Conveyance/Lease deed/Rent Agreement along with the rent receipts) etc-07072022
Copies of the utility bills as mentioned above (not older than two months)-07072022